Streetbeat News

MEDS

TRxADE HEALTH, Inc.

https://www.trxadehealth.com

Industry

Medical - Pharmaceuticals

TRxADE HEALTH, Inc. operates as a health services IT company in the United States. The company focuses on digitalizing the retail pharmacy experience by optimizing drug procurement, prescription journey, and patient engagement. It operates the TRxADE drug procurement marketplace, which fosters price transparency and serves approximately 11,800 members; and offers patient centric telehealth services under the Bonum Health brand name. The company was formerly known as Trxade Group, Inc. and changed its name to TRxADE HEALTH, Inc. in June 2021. TRxADE HEALTH, Inc. is based in Land O' Lakes, Florida.

Open

7.25

Mkt cap

13M

Volume

19K

High

7.70

P/E Ratio

-0.31

52-wk high

44.56

Low

7.06

Div yield

1.25

52-wk low

3.69

In Monday's pre-market session, several healthcare stocks showed significant movement. Notably, Applied DNA Sciences (APDN) surged by 33.1%, while Titan Pharma (TTNP) dropped by 18.2%. Other gainers include XTL Biopharmaceuticals (XTLB), 2seventy bio (TSVT), DBV Technologies (DBVT), Elicio Therapeutics (ELTX), and Moleculin Biotech (MBRX). Losers also featured Biophytis (BPTS), Molecular Templates (MTEM), Nanobiotix (NBTX), TC BioPharm (TCBP), and Trxade Health (MEDS).

Portfolio Pulse from Benzinga Insights

March 18, 2024 | 1:06 pm

In Thursday's after-market session, health care stocks saw significant movements. Geron (GERN) led the gainers with a 90.8% increase, while Kineta (KA) experienced the largest drop among the losers, declining by 8.3%. Notably, Akebia Therapeutics (AKBA) rose by 8.02% following its Q4 earnings report.

Portfolio Pulse from Benzinga Insights

March 14, 2024 | 9:33 pm

Health care stocks experienced significant movements in Wednesday's intraday session, with notable gainers including Heron Therapeutics, TRACON Pharma, NuCana, Kintara Therapeutics, Cardiff Oncology, and Annexon, showing increases ranging from 26.36% to 35.4%. On the downside, Trxade Health, Tenon Medical, P3 Health Partners, Envoy Medical, Neumora Therapeutics, and Aesthetic Medical Intl saw declines between 16.28% and 22.6%. These movements were influenced by factors such as Q4 earnings reports.

Portfolio Pulse from Benzinga Insights

March 13, 2024 | 5:31 pm

Mesoblast Limited's shares surged by 13.4% after announcing FDA support for an accelerated approval pathway for rexlemestrocel-L. Other stocks also saw significant movements, with Kidpik Corp. leading the gainers with a 238% increase following a reverse stock split announcement. On the losers' side, Jeffs' Brands Ltd dropped by 45.2%. The market movements were influenced by various factors including FDA approvals, strategic plans, financial results expectations, and investment proposals.

Portfolio Pulse from Avi Kapoor

March 11, 2024 | 5:41 pm

In Thursday's pre-market session, several healthcare stocks showed significant movement. NKGen Biotech, Nutex Health, Avinger, Exicure, Ventyx Biosciences, and Lucy Scientific Discovery were among the gainers, with increases ranging from 11.05% to 18.0%. On the downside, Avid Bioservices, Emergent BioSolutions, Nexalin Technology, CASI Pharmaceuticals, Immuron, and Trxade Health experienced declines between 8.81% and 37.4%. Emergent BioSolutions' drop was attributed to its Q4 earnings report.

Portfolio Pulse from Benzinga Insights

March 07, 2024 | 1:06 pm

In Wednesday's after-market session, several healthcare stocks showed significant movement. SCWorx (WORX) led the gainers with a 60.8% increase, while Nexalin Technology (NXL) experienced the largest drop among the losers, falling 14.4%. Notable mentions include IO Biotech (IOBT) and Vicarious Surgical (RBOT), which released their Q4 earnings recently, influencing their stock movements.

Portfolio Pulse from Benzinga Insights

March 06, 2024 | 9:31 pm

Nasdaq gained 100 points as U.S. stocks traded higher, with Campbell Soup Company (NYSE:CPB) reporting better-than-expected Q2 earnings. Information technology shares led gains, while consumer discretionary shares fell. Aptorum Group (NASDAQ:APM), TRxADE HEALTH (NASDAQ:MEDS), and Rail Vision Ltd. (NASDAQ:RVSN) saw significant stock increases. Conversely, Entravision Communications (NYSE:EVC), Neptune Wellness Solutions (NASDAQ:NEPT), and bioAffinity Technologies (NASDAQ:BIAF) experienced substantial declines.

Portfolio Pulse from Avi Kapoor

March 06, 2024 | 7:35 pm

In Wednesday's intraday session, several healthcare stocks experienced significant movements. Aptorum Gr (APM) led the gainers with a 780.6% increase, while bioAffinity Technologies (BIAF) headed the losers with a 45% decrease. Other notable movers included NKGen Biotech (NKGN), Trxade Health (MEDS), and Vincerx Pharma (VINC) among the gainers, and Heart Test Laboratories (HSCS), Ocean Biomedical (OCEA), and TC BioPharm (Holdings) (TCBP) among the losers.

Portfolio Pulse from Benzinga Insights

March 06, 2024 | 5:31 pm

Trading of TRxADE HEALTH, Inc. shares has resumed, indicating a return to normal trading activities for the company's stock.

Portfolio Pulse from Benzinga Newsdesk

March 06, 2024 | 5:15 pm

Shares of TRxADE HEALTH, Inc. were halted due to a circuit breaker triggered by a significant upside movement, with the stock surging 99.4%.

Portfolio Pulse from Benzinga Newsdesk

March 06, 2024 | 5:09 pm

All corporate logos and prices are for illustrative purposes only and are not a recommendation, an offer to sell, or a solicitation of an offer to buy any security.